GGrantIndex
Sort

64,565 grants matching drug discovery

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH

$1,441,119
Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2011 · RR

CATHEPSIN L INHIBITORS AS PAN-CORONAVIRUS THERAPEUTICS

$1,440,811
Doron Greenbaum · Phelix Therapeutics, Llc · R44 · FY2017 · AI

Cancer Research Center of Hawaii

$1,440,371
Michele Carbone · University Of Hawaii At Manoa · P30 · FY2008 · CA

Cancer Research Center of Hawaii

$1,440,370
Michele Carbone · University Of Hawaii At Manoa · P30 · FY2009 · CA

SPORE in Myeloid Malignancies

$1,440,214
Benjamin Levine Ebert · Brigham And Women'S Hospital · P50 · FY2018 · CA

Human pluripotent stem cells

$1,440,017
Pamela Robey · National Institute Of Neurological Disorders And Stroke · ZIC · FY2018 · NS

Adaptation of Influenza Inhibition Assays for High-throughput Screening

$1,439,620
James W Noah · Southern Research Institute · R01 · FY2006 · AI

High Throughput Screening for Ligands for Seven Transmembrane-spanning Receptors

$1,439,487
Marvin Gershengorn · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK

Discovery of Anticancer Agents of Diverse Natural Origin

$1,439,316
Alan Douglas Kinghorn · Ohio State University · P01 · FY2023 · CA

Endocannabinoid Active Sites as Therapeutic Targets

$1,438,465
Alexandros Makriyannis · Northeastern University · P01 · FY2025 · DA

Human Melanoma: Etiology, Progression and Therapy

$1,438,284
Meenhard Herlyn · Wistar Institute · P01 · FY2014 · CA

FAMILIAL PARKINSON'S DISEASE: CLUES TO PATHOGENESIS

$1,438,077
Brigham And Women'S Hospital · P50 · FY2002 · NS

Laser-based high content imaging microscope

$1,437,399
Jonathan Zachary Sexton · University Of Michigan At Ann Arbor · S10 · FY2024 · OD

FAMILIAL PARKINSON'S DISEASE: CLUES TO PATHOGENESIS

$1,436,314
Brigham And Women'S Hospital · P50 · FY2001 · NS

Predictive Guidelines for Penetrance and Discovery of Broad-Spectrum Antibiotics

$1,436,141
Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2018 · AI

Discovery of Anticancer Agents of Diverse Natural Origin

$1,436,095
Alan Douglas Kinghorn · Ohio State University · P01 · FY2021 · CA

Regulation of Ras-Dependent Signal Transduction Pathways

$1,435,512
Deborah Morrison · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways

$1,435,400
Matthew D Disney · Scripps Florida · P01 · FY2018 · NS

Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways

$1,435,400
Matthew D Disney · Scripps Florida · P01 · FY2019 · NS

Contraception by Blockade of Periovulatory Events in Primates

$1,435,158
Richard L Stouffer · Oregon Health & Science University · U54 · FY2013 · HD

Computational Molecular Pathology Research for Cancer Diagnostics and Biomarkers

$1,434,683
Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA

Endocannabinoid Active Sites as Therapeutic Targets

$1,434,681
Alexandros Makriyannis · Northeastern University · P01 · FY2023 · DA

Elucidating High Oral Fluid Exposure Mechanisms of Buprenorphine to Reduce Dental Caries

$1,434,060
Ming Hu · University Of Houston · R01 · FY2023 · DE

Prostate Cancer: Transition to Androgen - Independence (CA77739)

$1,433,904
Frank S French · Univ Of North Carolina Chapel Hill · P01 · FY2014 · CA

Chemistry and Synthesis Center (formerly IPDC)

$1,433,794
Rolf Swenson · National Heart, Lung, And Blood Institute · ZIC · FY2023 · HL